Objective: This study tested the hypothesis that PAD4 and NETs influence experimental atherogenesis and in processes implicated in superficial erosion, a form of plaque complication we previously associated with NETs. 
D
espite current therapies, acute coronary syndromes (ACS) remain one of the leading causes of mortality globally. For decades, pathological studies and fundamental research have focused primarily on the so-called vulnerable plaque. Such work has enabled tremendous advances in understanding the mechanisms of formation, development, and complication of thin-capped atheromata, a morphology associated with plaque rupture and thrombosis.
1,2 Decades of therapies that have successfully lowered exposure to traditional risk factors such as LDL (low-density lipoprotein), hypertension, and smoking may have altered human atheromata, increasing the proportion of ACS caused by superficial erosion. 3 Lesions associated with superficial erosion in humans exhibit a very distinct morphology from thin-capped atheromata associated with plaque rupture. 4, 5 In contrast to ruptured plaques, those complicated by erosion exhibit less lipid, macrophage/foam cell accumulation, and more smooth muscle cells (SMC) and collagen in the fibrous cap. Plaques associated with superficial erosion contain abundant SMC and extracellular matrix. Recent data obtained using intravascular optical coherence tomography indicate that up to one-third of ACS in the current era result from erosion rather than rupture. 6 
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Neutrophils, key contributors to the acute phase of innate immunity, may contribute to atheromata formation, by the promotion of inflammatory monocyte recruitment, 7 and may also participate in lesion evolution and complication. Yet the extent and timing of potential neutrophil involvement in human atherosclerosis remain unsettled. 8, 9 Although experimental atheromata in severely hypercholesterolemic mice contain neutrophils, the paucity of validated selective markers for human neutrophils has rendered their identification in pathological studies difficult. Furthermore, neutrophils may undergo phenotypic changes and modulate into antigen-presenting cells such as dendritic cells or phagocytic cells. 10, 11 Our recent experiments have implicated neutrophils in processes postulated to pertain to superficial erosion. These results heightened the need to understand more fully mechanisms by which neutrophils might contribute to thrombotic complications of atherosclerosis prompted by superficial erosion. We previously reported that TLR (Toll-like receptor)-2 ligation can activate endothelial cells (ECs) through NFκB, and potentiate neutrophil recruitment. 12 Using a novel approach, 13 we also found that neutrophils play a pivotal role in intimal injury in superficial erosion. Human atheromata harvested from carotid arteries showed localization of cells bearing CD66b, MPO (myeloperoxidase) and neutrophil elastase near luminal ECs supporting the presence of granulocytes at the intimal surface of lesions that required clinically-indicated endarterectomy. Activated neutrophils can release their cytoplasmic content and extrude their DNA in a process known as NETosis. Many effector mediators festoon this extracellular neutrophil DNA, including histones, multiple proteinases, and the pro-oxidant enzyme MPO. Neutrophil extracellular traps (NETs) exposed to blood also gather the potent procoagulant tissue factor. NETosis was originally described as a mechanism of defense against bacteria, 14 but also participates in pathological thrombosis, including deep vein thrombosis 15 and atherothrombosis. 16, 17 Mediators associated with NETs can stimulate inflammatory cells ranging from plasmacytoid dendritic cells 18 to macrophages. 19 Recent insight suggests a role of NETs in macrophage activation, potentiating plaque formation in murine atherosclerosis. 19 Yet, few studies have examined directly the effect of NETs on the formation, development, and the complication of atherosclerosis. The enzyme PAD4 (peptidyl arginine deiminase 4) participates in NET formation by converting arginyl residues in histones of chromatin to citrulline (which lacks the positive charge of arginine), releasing the ionic bonds that usually constrain nuclear DNA to nucleosomes. Loss of the positive charge on the guanidino group of arginine because of PAD4 action frees the strands of DNA to unfurl and form the solid-state reactor furnished by NETs. Indeed, NET formation requires PAD4. 20 Inhibition of PADs with chloramidine prevented NETosis, reduced atheromata burden, and retarded neutrophil and monocytes recruitment to arteries. 21 Yet, the lack of specificity of this inhibitor does not permit unambiguous probing of the role of PAD4 and NETs in atherothrombosis. Therefore, we undertook to evaluate the participation of PAD4 and NETs in atherothrombosis using mice with genetic deficiency of PAD4 in blood cells as a more rigorous tool.
This study demonstrates that PAD4 of bone marrow origin and NETs do not influence experimental atherogenesis but are involved in acute thrombotic complications recapitulating features of superficial erosion.
Methods
Additional data are available on request from the lead author (gregory.franck@inserm.fr).
Human Specimen
Plaques from human diseased carotid arteries were harvested during clinically-indicated endarterectomy according to protocols approved by the Brigham and Women's Hospital Human Investigation Review Committee (Boston). Carotid samples were cryosectioned and classified according to their morphology (Online Figure I) . Human coronary arteries and aortas were harvested according to protocols approved by the INSERM ethics committee. Coronary arteries were isolated from hearts of cardiac transplant recipients with ischemic heart disease or hypertrophic cardiomyopathy. Coronary arteries were classified according to their localization, atheromatous status, nature of the donor, and then stored in a biobank (INSERM U1148, Bichat Hospital, Paris, France). 
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Flow-Mediated Superficial Erosion
Atheromata with features associated with superficial erosion were produced as previously described. 13 Briefly, 8-week-old Ldlr −/− mice underwent electrical current injury of the left common carotid artery (LCCA) using a bipolar microcoagulator (Erbe ICC 200) with a current pulse of 3 W. This treatment resulted in reproducible neointima formation (Online Figure IV) . Four weeks later, local flow perturbation was induced proximal to the healed injury, using constrictive polyethylene cuffs manufactured to our specifications by 3-dimensional stereolithography printing (Proto Labs; Online Figure V) . The nonconstrictive proximal internal diameter (500 µm) of the cuff decreases gradually to become constrictive at its end (distal internal diameter: 250 µm). Previous work formally characterized the flow disturbance produced distal to the cuff using direct measurements and computational fluid dynamics. Animals that underwent a sham procedure (with no cuff placement) and those that had placement of a nonconstrictive device served as controls for the surgical manipulations and for adventitial injury and inflammation.
Biological Analysis
Flow perturbation continued for 1 or 6 hours, and mice were euthanized by CO 2 inhalation and bilateral thoracotomy. After peripheral blood sampling, mice were perfused via left ventricular cannulation with cold PBS and then fixed with 4% paraformaldehyde. Distal and proximal LCCA samples were collected and embedded in optimal cutting temperature medium. Six µm cryosections were prepared and stained for immunohistochemistry/immunofluorescence investigation.
Immunohistochemistry/Immunofluorescence
Immunostaining of frozen cross sections used a rat monoclonal anti-mouse Ly6G (clone 1A8), rabbit polyclonal anti-citrullinated Histone H3 (H3cit, Abcam) and anti-citrullinated Histone H4 (H4cit, Millipore), a rat monoclonal anti-CD31 (BD Pharmingen), a rabbit polyclonal anti-CD66b (Abcam), or a rabbit polyclonal anti-MPO (DAKO). Immunostaining was performed on human coronary artery ECs (HCAEC) using a rabbit anti-C5b-9 complement (Abcam) or a rabbit anti-VE-Cadherin (Abcam). Apoptotic ECs were visualized using fluorescent in situ DNA strand breaks detection kit (TUNEL [Terminal deoxynucleotidyl transferase dUTP nick end labeling], Roche). Immunostaining was amplified using peroxidase-conjugated streptavidin complexes (Vector Laboratories), and peroxidase was detected using AEC (Vector Laboratories) substrate. Sections were lightly counterstained with hematoxylin, mounted in gelatin-glycerol and examined with a bright field microscope (Nikon Optiphot-2 equipped with a Nikon digital camera DXM 1200F). For double immunostaining studies, cross sections were incubated with primary antibodies followed by incubation with fluorophore-coupled antispecies antibody (Life Technologies), stained with DAPI, and mounted with fluorescent mounting medium (DAKO). Slides were kept in the dark at 4°C.
H3cit Sandwich-ELISA Assay
Ninety-six-well plates were coated with appropriate dilutions of commercially available monoclonal mAb 11D1 mouse anti-Histone H3 (citrullinated R2+R8+R17, N-Terminal sequence; Cayman number 17939), washed, and incubated with mouse plasma samples. After washing, the wells were incubated with biotinylated rabbit monoclonal antibody to the C-terminal sequence of Histone H3, followed by incubation with streptavidin covalently conjugated to horseradish peroxidase. After washing and addition of appropriate fluorogenic or chromogenic horseradish peroxidase substrates, fluorescence or absorbance was determined using a plate reader. A truncated H3cit peptide containing both the N-and C-terminal sequences linked by a poly-GC flexible linker (Online Figure VI ) was used as a standard.
Endothelial Permeability
Endothelial permeability in vivo was investigated by monitoring extravasation of Evans Blue dye (EBD, Sigma). Mice with previously tailored intimas were injected retro-orbitally with 50 µL of 7% EBD 6 hours after flow perturbation. After 10 minutes, mice were euthanized by CO 2 inhalation, perfused by left ventricular apical cannulation with PBS at 4°C supplemented with 10 U/mL heparin, and were then fixed by a 10% formalin perfusion. LCCA were embedded in optimal cutting temperature and kept at −80°C for histological examination. LCCA were harvested en bloc, opened longitudinally from the aortic arch to the bifurcation and stabilized on the glass with hardening mounting medium (Vector, Vecta Mount H-5000). Arteries were examined by bright field imaging.
En Face Microscopy
Mouse vasculature was rinsed with perfusion of cold PBS followed by fixation with cold 4% paraformaldehyde. Carotids (n=8 per group) were dissected and opened longitudinally on a Sylgard dish and fixed in 4% paraformaldehyde for 48 to 72 hours. Fixation was quenched with 100 mmol/L glycine (pH 7.4). After extensive washing with PBS, arteries were permeabilized and treated with blocking buffer containing 5% native goat serum, 1% bovine serum albumin, and 0.05% Triton X-100 during 2 hours at room temperature. Primary antibodies were diluted in blocking buffer and incubated with carotid artery specimens for 48 hours at 4°C. After washing in PBS and in blocking buffer for 2 hours, the carotids were incubated with fluorophoreconjugated antibodies diluted in blocking buffer for 1 hour at room temperature. Finally, tissues were washed in blocking buffer for 1 hour at room temperature, then washed in PBS, mounted with Vectashield HardSet Antifade Mounting Medium containing DAPI for DNA staining (Vector Laboratories) and stored in the dark at room temperature.
Bone Marrow Transplantation
Recipient Ldlr −/− male C57B6 mice (6-to 8-weeks-old) received 1050 rads of split-dosed lethal irradiation (5.25 Gy, twice) 4 hours apart to reduce gastrointestinal toxicity, and antibiotics (sulfamethoxazole and trimethoprim, HiTech Pharmacal) until the end of the experiment. Total bone marrow cells from WT or Pad4 −/− donor mice were prepared from femurs and tibias collected aseptically in RPMI (Roswell Park Memorial Institute) 1640 medium supplemented with 2% FBS, 10 U/mL heparin, penicillin, and streptomycin. Bones were punched with a needle at both extremities and centrifuged. Cells were resuspended and washed twice in serum-free RPMI 1640 medium supplemented with 20 mmol/L HEPES, penicillin, and streptomycin at pH 7.4. Five million total bone marrow cells were injected intravenously into each 6-week-old recipient mouse for reconstitution. Mice without bone marrow reconstitution served as sentinels. Mice were monitored until the final experiments, and survival curves were established for each group (Online Figure IIA) .
In Vitro Adhesion Experiment
Neutrophils from both WT and Pad4 −/− mice from bone marrow were isolated after flushing whole bone marrow cells and lysing red blood cells, neutrophil granulocytes were isolated by negative selection using a neutrophil isolation kit (Miltenyi Biotec). Isolated neutrophils were then labeled with calcein (Invitrogen) according to manufacturer's instructions and incubated with resting or TNF (tumor necrosis factor)-α-activated mouse aortic ECs (20 ng/mL; 6 hours at 37°C) for 15 minutes at 37°C.
Human NET Isolation
Human neutrophils were isolated from EDTA-treated fresh blood obtained from Bichat Hospital (Paris, France). NETs were generated by stimulating neutrophils with 50 nmol/L phorbol myristate acetate for 4 hours and isolated as previously described with slight modifications. 22 After 4 hours, neutrophils were gently washed with PBS and NETs were harvested by pipetting. Neutrophils that did not form NETs were discarded. Solid phase DNA was washed and sonicated for 5 minutes at 37°C to allow for homogenization. DNA quantification was performed using Sytox green nucleic acid labeling (Thermo Fisher Scientific).
Cell Culture and Incubation With NETs
HCAECs (Lonza) were cultured on plates coated with 100 µg/mL type 1 collagen (Thermo Fisher Scientific) in EGM-2 MV (Lonza) supplemented with 15% FBS (Gibco). After reaching confluence, HCAECs were conditioned either in 15% FBS or 15% baby rabbit serum (BRS; Cedarlane Corporation), decomplemented or not by treatment at 56°C for 30 minutes, and incubated with 1.5 mg/mL NETs for 6 hours. The supernatants were harvested for detached cells count, and the attached cells were washed and fixed in 2% paraformaldehyde for further immunocytofluorescence analysis.
Image Acquisition and Morphometric Analysis
In situ images were captured digitally using a BX61WI microscope coupled with a Fluoview FV1000 confocal unit (Olympus) equipped with an Olympus DP72 camera and running Fluoview 10-ASW Software (Olympus) for confocal microscopy or with a Nikon Optiphot-2 equipped with a Nikon digital camera DXM 1200F for bright field microscopy. Macroscopic images were captured using the confocal apparatus and Cell Sens software (Olympus). The number of Ly6G-positive cells, CD31-positive cells, CD31 + TUNEL + cells, endothelium continuity, and EBD coverage were quantified by computer-assisted immunostaining (Image-Pro Plus, Media Cybernetics) using a double-blind randomized approach.
Statistics
Animals were randomly allocated to treatment or control groups. Investigators were blinded to the group allocation during the experiment. Data were analyzed to assess normality of distribution. A nonparametric test was used for skewed data. For normally distributed variables, data were expressed as mean±SEM and analyzed by the t test, Mann-Whitney or Kruskal-Wallis 1-way ANOVA and Dunn post hoc test (GraphPad Prism). Differences were considered statistically significant at the P<0.05 level (unadjusted P values). Correlation was estimated with Pearson product-moment.
Results
NETs Localize Differentially in Human Carotid Plaques With Erosion-Prone Versus Rupture-Prone Characteristics
Our recent study classified atherosclerotic lesions from our human carotid endarterectomy tissue collection by morphological criteria as erosion-prone or rupture-prone. 12 Localization of NET markers in plaques classified by the same criteria (Online Figure I) , revealed a differential presence of NETs in lesions with rupture-prone versus eroded characteristics, as assessed by staining for the membraneassociated neutrophil marker CD66b, neutrophil elastase, an enzyme released by activated neutrophils implicated in vascular damage, and the NET marker H4cit ( Figure 1A and 1B). As opposed to rupture-prone plaques, plaques with erosion-prone characteristics demonstrated colocalization of neutrophil elastase and H4cit, mainly in contact with the luminal surface. NETs were also qualitatively localized (n=8) in longitudinally-sectioned human coronary arteries isolated freshly from explanted hearts from patients undergoing transplantation ( Figure 1C ). NETosing neutrophils could be The panels on the right show H4cit, NE, and DAPI immunofluorescence within the intima. B, Carotid artery plaques with erosion-prone morphology stained by immunohistochemistry for neutrophils (CD66b), neutrophil elastase (NE), and citrullinated histones (H4cit). The panels on the right show H4cit, NE, and DAPI positive NET structures by immunofluorescence at the intima surface. Scale bar: 150 µm. C, Shows a representative longitudinal section of a human left coronary artery stained for CD31, H4cit, and DNA (DAPI). Elastin autofluorescence is in white. The 4 insets show specific areas containing NETosing neutrophils in both plaques (D and E) and near eroded luminal endothelium (F and G), as shown with CD31, H4cit, and DAPI staining, and an adjacent section stained for CD31, CD66b, and DAPI. Arrows show flow orientation. Arrowheads show the limit of local endothelial denudation. * indicate lumen. NET visualization in space after 3-dimensional reconstruction from plaques (H) and eroded endothelium (I).
observed within atheromata ( Figure 1D and 1E) and in contact with the luminal surface in areas with EC denudation ( Figure 1F ) or exhibiting a luminal thrombus ( Figure 1G ) as shown in a representative specimen. In both cases, further characterization of NET structure used a 3-dimensional reconstruction approach ( Figure 1H and 1I ).
PAD4 Deficiency Confined to Bone Marrow-Derived Cells Does Not Impede Fatty Streak Formation or Prevent Plaque Formation
Investigation of the impact of PAD4 deficiency limited to bone marrow-derived cells on atherogenesis used chimeric mice. Eight-week-old Ldlr −/− mice underwent lethal irradiation, followed by reconstitution with bone marrow either WT or Pad4 −/− animals, and subsequent consumption of high fat diet (HFD) for 5 or 10 weeks (Figure 2A ). The groups of bone marrow chimeric mice had similar blood cholesterol concentrations (Online Figure IIC) . Likewise, the lipid content of aortae from these groups did not differ significantly, as assessed by Oil Red O staining ( Figure 2B , 2C, 2E, and 2F). Furthermore, PAD4 deficiency altered neither plaque size ( Figure 2C and 2D ) nor macrophage accumulation after either 5 or 10 weeks of HFD ( Figure 2G and 2H) . Aortic root fatty streaks did not contain SMCs after 5 weeks of HFD in either group of mice ( Figure 2I and 2J) . SMCs accumulated in the fibrous cap region after 10 weeks of HFD, but the SMC area and the collagen content did not differ between the 2 groups of bone marrow chimeric mice ( Figure 2I through 2L) . Altogether, these data indicate that PAD4 deficiency limited to hematopoietic cells did not modulate plaque burden or features implicated in stability.
PAD4 Deficiency Abrogates NETosis in Experimental Atheromata
Brachiocephalic artery and aortic root plaques of mice lethally irradiated and reconstituted with wild-type bone marrow ( Figure 3A) contained NETs, as assessed by the colocalization of diffuse DNA and H4cit in neutrophil-rich areas ( Figure 3B and 3C) . In contrast, mice reconstituted with Pad4 −/− bone marrow never showed diffuse extracellular H4cit/DNA, indicating that plaque NETosis depends on PAD4 in bone marrow-derived cells. Quantification of H3cit −/− bone marrow showed a nonsignificant trend to decreased neutrophil accumulation within atheromata ( Figure 3F and 3G ). Yet, the number of circulating neutrophils (Online Figure III) , and their ability to adhere to ECs in vitro ( Figure 3H ) was similar in WT mice and Pad4 −/− mice.
Flow Perturbation at Sites of Intimal Expansion Promotes Accumulation of NETosing Neutrophils
Eight-week-old Apoe −/− mice underwent LCCA injury to produce intimal lesions that replicate aspects of plaques associated with human eroded lesions, followed 4 weeks later by induction of local flow perturbation with a constrictive cuff during 1 hour ( Figure 4A ). These sequential manipulations yielded deposition of H3cit on the LCCA lumen ( Figure 4B and 4C ), which colocalized with and correlated positively with the number of adherent neutrophils (Ly6G + cells; Figure 4D and 4E). In contrast, neither sham arterial cut down nor the placement of a nonconstrictive cuff elicited H3cit deposition. Sites of flow perturbation contained granular structures in contact with a disrupted luminal ECs layer and platelets, as revealed by scanning electron microscopy ( Figure 4F ), and neutrophils extruding DNA observed by en face microscopy ( Figure 4G ). These structures contacted the endothelium closely and colocalized with H3cit and MPO ( Figure 4H) . Finally, the mice that underwent flow perturbation had higher plasma concentrations of H3cit than the control groups ( Figure 4I ). Collectively, these results indicate that flow perturbation at sites of intimal expansion fosters neutrophil recruitment and NETosis. 
PAD4 Deficiency in Bone Marrow-Derived Cells or DNaseI Administration Abrogated NETosis and Prevented Endothelial Injury and Thrombus Formation
Further experiments to test the hypothesis that NETs promote EC injury in experimental superficial erosion, used PAD4 deficiency in bone marrow-derived cells to halt the ability of neutrophils to undergo NETosis. Eight-week-old Ldlr −/− male mice underwent electrical injury to the LCCA and then consumed a modified HFD (1.25% cholesterol). Four weeks after the procedure, mice underwent lethal irradiation and reconstitution with either WT or Pad4 −/− -deficient bone marrow cells ( Figure 5A ). Survival curves, intima:media ratio in harvested LCCA samples, blood cholesterol (Online Figure IIA through  IIC) , and the number of circulating monocytes and neutrophils (Online Figure II) did not vary significantly between groups, whereas the levels of circulating H3cit tended to decrease in mice reconstituted with Pad4 −/− cells ( Figure 5B ). Two weeks after bone marrow reconstitution, constrictive cuff placement produced local flow perturbation in the artery with the tailored neointima during 6 hours. LCCAs in mice reconstituted with Pad4 −/− cells exhibited less intimal permeability after 6 hours of flow perturbation as assessed by Evans blue staining ( Figure 5C ), and decreased neutrophil accumulation in the intima (Online Figure IID) . Although regions of flow perturbation in the carotid arteries of mice with WT bone marrow showed NETs in contact with luminal ECs (Figure 5D, top) , hematopoietic PAD4 deficiency abrogated intimal NETosis (Figure 5D, bottom) , and protected intimal integrity as gauged by the preservation of endothelial continuity ( Figure 5E ). The preservation of luminal ECs in mice with Pad4 −/− bone marrow associated with smaller intraluminal thrombus ( Figure 5F ), decreased luminal tissue factor ( Figure 5G ) and decreased the number of intimal TUNEL + cells (Online Figure IIE) . Flow perturbation associated with the accumulation of MPO + cells and tissue factor in the subendothelial layer (Online Figure  IIF ). An alternative strategy to address the role of NETs on luminal EC injury involved the administration of soluble DNaseI or vehicle before flow perturbation for 6 hours ( Figure 5H ). DNaseI treatment protected the endothelium downstream + luminal cells ( Figure 5K ). As previously observed, the number of adherent Ly6G + cells decreased in the DNAseI group, suggesting decreased local inflammation (Online Figure IIG) . Together these results using independent methods that perturb NET formation or NET degradation demonstrate in vivo that NETs jeopardize EC survival, adhesion, and barrier function.
NETs Promote EC Death and Detachment in a Complement-Dependent Manner
Flow perturbation associated with complement accumulation at the vicinity of experimentally eroded lesions in mice (Online Figure VIIA) . We next explored the contribution of complement activation to NET-induced damage of cultured human ECs. Exposure of primary HCAEC to NETs prepared from phorbol myristate acetate-stimulated neutrophils increased VCAM (vascular cell adhesion molecule)-1 expression (Online Figure VIIB) and augmented EC apoptosis (Online Figure VIIC) . Pretreatment of NETs with DNase I eliminated NET-induced apoptosis (Online Figures VIIC and  VIID) . EC culture using complement-rich BRS increased complement deposition on cells assessed by C5b-9 staining (Online Figure VIIE) . BRS markedly enhanced the apoptotic cell count when added with NETs, as compared with BRS alone (Online Figure VIIF and VIIG) . HCAEC apoptosis declined significantly in cells exposed to BRS decomplemented by heat treatment compared with untreated BRS (Online Figure VIIF and VIIG) . In addition, the combination of BRS and NETs augmented HCAEC detachment, an effect mitigated by heat decomplementation of BRS (Online Figure VIIH) .
Discussion
NETosis in mice depends on PAD4 activity. In addition to mediating NETosis, PAD4 activity can also affect SMC activation. 23 A previous study reported that Cl-amidine, a pan-PAD inhibitor administered systemically, reduced experimental atherosclerosis in mice. 21 Yet, the lack of selectivity of Clamidine considerably limits the interpretation of experiments that used this small molecule inhibitor. We, therefore, studied mice with selective genetic deficiency of PAD4 in bone marrow-derived cells, abolishing PAD4 activity in leukocytes but not in intrinsic vascular wall cells and other tissues.
PAD4 deficiency in hematopoietic cells did not significantly alter the formation and progression of atheromatous plaques in hypercholesterolemic mice. Yet, it critically attenuated the response to flow perturbation of arterial regions with experimentally expanded intimas. These observations implicate NETosis in this form of atherothrombotic complication which recapitulates features of superficial erosion. Conversely, the lack of effect on atherosclerosis of PAD4 deficiency in bone marrowderived cells in the present experiments indicates that PAD4 does not play an essential role in the earlier stages of lesion formation. The slight reduction in neutrophil number in mice with PAD4-deficient bone marrow is surprising. In this regard, although PAD4 reportedly regulates the proliferation of hematopoietic stem cells, 24 our results show that Pad4 −/− mice have similar levels of circulating neutrophils and monocytes as their WT counterparts. Additionally, PAD4 deficiency did not alter neutrophil adhesion to ECs in vitro, suggesting that decreased neutrophil number in superficial erosion in vivo likely reflects locally decreased inflammation, because of impaired NETosis.
Yet, this study has certain limitations. Various other hematopoietic cell types, including mast cells and macrophages, may undergo NETosis. 25 The experiments presented here do not distinguish the effects of NETs derived from granulocytes from those induced by such other hematopoietic cells. Also, the flow perturbation used in these experiments to trigger intimal dysfunction was acute and of relatively brief duration compared with conditions that may prevail in human superficial erosion. Yet, the use of this preparation contributes to a growing body of evidence that NETs participate in the propagation of plaque erosion.
Our experimental approach to study intimal functions related to superficial erosion showed that PAD4 deficiency in hematopoietic cells significantly preserved endothelial barrier function after acute perturbation of blood flow protected ECs from desquamation, and decreased their death. Therefore, NETs seem to jeopardize normal endothelial functions and thus represent a novel target for the treatment and prevention of thrombotic complications of atherosclerosis including superficial erosion. Systemic treatment with DNaseI merits consideration as a therapeutic approach. Indeed, formulations of DNase I (Pulmozyme) approved for the treatment of cystic fibrosis 26 exert beneficial effects in mice with experimental inflammation and thrombosis. In addition, levels of circulating markers associated with NET (citrullinated histones, free DNA, and MPO) could help to diagnose superficial erosion and to triage the treatment of ACSs in a more personalized approach than currently practiced, 27 a prospect supported by an early biomarker study in individuals with atherothrombosis. 17 In this regard, a recent preliminary clinical study reported the efficacy of an antithrombotic strategy without intravascular intervention for the treatment of ACS provoked by superficial erosion. 28 Our data suggest a role for the complement pathway in NET-induced EC death and detachment. NETs can activate the alternative complement pathway 29 and promote endothelial damage affecting glomeruli in antineutrophil cytoplasmic antibody-associated vasculitis. 30 NETs could constitute a critical scaffold promoting the local activation of the complement pathway in the vicinity of vascular ECs, exacerbating EC death, detachment, and thrombosis. Thus, strategies that limit complement activation also merit consideration as an adjunct to treatment of the subset of ACS because of superficial erosion. 31 Overall, this study using genetic approaches to interfere with NET formation provides experimental evidence for a stage-specific contribution of NETs to atherosclerosis and its thrombotic complications. These findings have important translational implications for diagnosis, therapy, and management of patients with or at risk for atherothrombosis.
